Publications Database

Anderson L. T. et al. (1984)

Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms

American Journal of Psychiatry

141(10), pp. 1195-1202

Read Abstract (New Window)

Anderson L. T. et al. (1989)

The effects of haloperidol on discrimination learning and behavioral symptoms in autistic children.

Journal of Autism and Developmental Disorders

19(2), pp. 227-239

Read Abstract (New Window)

Armenteros J. et al. (1995)

Haloperidol-related dyskinesias and pre- and perinatal complications in autistic children.

Psychopharmacology Bulletin

31(2), pp. 363-369

Read Abstract (New Window)

Campbell M. et al. (1978)

A comparison of haloperidol and behavior therapy and their interaction in autistic children.

Journal of the American Academy of Child and Adolescent Psychiatry

17(4), pp. 640-655

Read Abstract (New Window)

Campbell M. et al. (1978)

A controlled crossover study of triiodothyronine in autistic children.

Journal of Autism and Child Schizophrenia

8(4), pp. 371-381

Read Abstract (New Window)

Campbell M. , Geller B. , Cohen I. L. (1977)

Current status of drug research and treatment with autistic children.

Journal of Pediatric Psychology

2(4), pp. 153-161

Read Abstract (New Window)

Campbell M. et al. (1971)

Imipramine in preschool autistic and schizophrenic children.

Journal of Autism and Developmental Disorders

1(3), pp. 267-282.

Read Abstract (New Window)

Campbell M. et al. (1976)

Levodopa and levoamphetamine: a crossover study in young schizophrenic children.

Current Therapeutic Research

19(1), pp. 70-86

Campbell M. et al. (1990)

Naltrexone in autistic children: a double-blind and placebo-controlled study.

Psychopharmacology Bulletin

26(1), pp. 130-135

Read Abstract (New Window)

Campbell M. et al. (1989)

Naltrexone in autistic children: an acute open dose range tolerance trial.

Journal of the American Academy of Child and Adolescent Psychiatry

28(2), pp. 200-206

Read Abstract (New Window)

Campbell M. et al. (1993)

Naltrexone in autistic children: behavioral symptoms and attentional learning.

Journal of the American Academy of Child and Adolescent Psychiatry

32(6), pp. 1283-1291

Read Abstract (New Window)

Campbell M. (1998)

Naltrexone in infantile autism.

Psychopharmacology Bulletin

24(1), pp. 135-139

Campbell M. (1975)

Pharmacotherapy in early infantile autism.

Biological Psychiatry

10(4), pp. 399-423

Read Abstract (New Window)

Campbell M. , Cueva J. E. (1995)

Psychopharmacology in child and adolescent psychiatry: a review of the past seven years: Part 1

Journal of the American Academy of Child and Adolescent Psychiatry

34(9), pp. 1124-1132

Read Abstract (New Window)

Campbell M. et al. (1972)

Response to triiodothyronine and dextroamphetamine: A study of preschool schizophrenic children.

Journal of Autism and Developmental Disorders

2(4),

Read Abstract (New Window)

Campbell M. et al. (1986)

Short-term efficacy and safety of fenfluramine in hospitalized preschool-age autistic children: an open study.

Psychopharmacology Bulletin

22(1), pp. 141-147

Campbell M. et al. (1990)

Stereotypies and tardive dyskinesia: abnormal movements in autistic children.

Psychopharmacology Bulletin

26(2), pp. 260-266

Read Abstract (New Window)

Campbell M. et al. (1982)

The effects of haloperidol on learning and behavior in autistic children.

Journal of Autism and Developmental Disorders

12(2), pp. 167-175

Read Abstract (New Window)

Ernst M. et al. (1993)

Plasma beta-endorphin levels, naltrexone, and haloperidol in autistic children.

Psychopharmacology Bulletin

29(2), pp. 221-227

Read Abstract (New Window)

Gonzalez N. M. et al. (1994)

Naltrexone plasma levels, clinical response and effect on weight in autistic children.

Psychopharmacology Bulletin

30(2), pp. 203-208

Read Abstract (New Window)